We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on CMC Submissions for Gene Therapies
FDA Finalizes Guidance on CMC Submissions for Gene Therapies
April 11, 2008
The FDA is detailing its expectations for chemistry, manufacturing and control information that is included in INDs for gene therapies.